Join Shaklee and Try Cinch for FREE.....

Join Shaklee and Try Cinch^® for FREE*

(January – March 2012)

What?  Whenever you sponsor new people with a minimum $70 order, including any GOLD PAK, they will receive a Cinch Sampler Pack for free – a more than $100 SRP value! 

Why?  It’s weight loss season, and you’ll want everyone to get a taste of our clinically tested Cinch Inch Loss Plan. This gives your new Member, Distributor or Gold Ambassador the chance to try the delicious Cinch products for free, and then decide if they’re ready to commit to healthy transformation, with the Cinch Transformation Pack. 

Shaklee Videos: Happy Holidays from Shaklee!

Shaklee Videos: Happy Holidays from Shaklee!

Shaklee Videos: Moms

Shaklee Videos: Moms

~How the Shaklee Business Works~

Amazing Shaklee Videos....Come Watch!

"Share Your Story" Shaklee Videos......

Nathan & Jenni Oates

Cade VanHeel

Kyle & Kara Sears

Shaklee Videos: Roger Barnett on What Makes Shaklee Different

Shaklee Videos: Roger Barnett on What Makes Shaklee Different

Shaklee China One Year Anniversary

Interested in starting a Shaklee business in China?

Come watch this....................

Shaklee Videos: Part 3 - Shaklee China One Year Anniversary

Have questions or want more information? Contact Amber: abernhardt@earthlink.net

Vitalizer is out of this world.....Literally!!!

Astronaut Captain Mark Kelly was a speaker at the Shaklee Conference in Washington D.C. this year.  He was the captain of the historic & final NASA mission on July 8, 2011 and has been into space more than any other astronaut.  Many people know him as the husband of Arizona Congress Woman Gabriel Giffords who was shot earlier this year.


On NASA’s final mission, Capt. Kelly personally shot video of the Vitalizer vitamins in outerspace which was so fun to see!

Vitalizer Video

~"FREE" Membership with Vitalizer Purchase~

Buy Shaklee Vitalizer™ and Get a FREE Membership!
Get a free Shaklee Membership (a $19.95 value) and additional 15% savings on future purchases when you purchase Shaklee Vitalizer™. Vitalizer provides the best nutritional science in one convenient daily serving. Pure and GREEN nutrition supplements!

Introducing New & Improved Shaklee Vitalizer™

Vitalizer is the most advanced multinutrient supplement pack in the marketplace today, and it features a patent-pending delivery system designed to enhance absorption of key nutrients. Vitalizer is more than just a single multivitamin—with 80 bio-optimized nutrients clinically proven to create a foundation for a longer, healthier life, it’s the only comprehensive multinutrient supplement pack you need. There’s a Vitalizer that’s right for everyone.
Backed by 55 years of nutrition science, a first-of-its-kind Landmark Study, 12 clinical trials, and with formulas that target the specific health needs of men, women, and active adults, Shaklee Vitalizer is the first step toward an optimal nutritional foundation.

Join Now, Click Here!

Shaklee Videos: 2011 Shaklee Global Conference in D.C. - Day One Highlights!

Shaklee Videos: 2011 Shaklee Global Conference in D.C. - Day One Highlights!

Free Membership Offer/ "New" Member Referral Program

A New Shaklee Special and a FREE Membership opportunity!

The New Shaklee Member Referral Program

"Thank You Payments" for Your Members

I am so grateful and thankful for all of my Shaklee members and distributors and people who have purchased Shaklee from my Website. Now Shaklee has a way for our members to be rewarded as well and get compensation, even if they aren’t distributors!
 

How It Works

Your Member sends a special invitation message (with a specially coded link) from the MyShaklee.com site via Facebook, Twitter or email to a friend.

Friend uses the link to visit a special site where they purchase products, and they automatically get a one-time 15% discount.

If the order totals $25 Member Price (MP) or more (excluding taxes, shipping and handling), the referring Member gets a $25 credit they can apply to their next order of Shaklee products. That's it! You can do this as many times as you like, up to 100 referrals per day, and Shaklee does all of the tracking so that you get credit for all purchases! 

ALSO you can get a FREE Shaklee Membership by purchasing a Shaklee Vitalizer Pack!

Buy Shaklee Vitalizer™ and Get a FREE Membership!
Get a free Shaklee Membership (a $19.95 value) and additional 15% savings on future purchases when you purchase Shaklee Vitalizer™.  Vitalizer provides the best nutritional science in one convenient daily serving.

Telomere's...."key" to aging & cancer?

Announcing...

The Shaklee Telomere Research Landmark Study ll

        Thanks to the fist Landmark Study ever on the long term use of supplements,

Shaklee is the only company in the world with scientific proof that our products work.

Shaklee partnered with Dr. Gladys Block and her team at U.C. Berkeley for this study

which took three years, costing more than a million dollars,  and was published in

a peer review journal.

If you haven't seen the Landmark Study, go here…

http://landmarkstudy.com/

        This time, Shaklee is partnering with Dr. Elizabeth Blackburn

of the University of California, San Francisco. Dr. Blackburn is a

Nobel Prize winner in physiology or medicine.

Learn more about Dr. Blackburn' telomere research here...

http://biochemistry.ucsf.edu/labs/blackburn/index.php?option=com_content&view=article&id=1&Itemid=3

She discovered how chromosomes are protected by telomeres

and the enzyme telomerase.

This study on DNA and longevity will include 107 Shaklee participants

who have been taking Shaklee (Vitalizer, Vivix and Cinch)

for approximately five years — as well as a group of non supplement users.

Preliminary results of the study are very impressive.

What are telomeres?

Telomeres are biomarkers of aging. They could be the key to

aging and cancer.

Inside the center or nucleus of a cell, our genes are located on twisted,

double-stranded molecules of DNA called chromosomes.

At the ends of the chromosomes are stretches of DNA called telomeres,

which protect our genetic data, make it possible for cells to divide,

and hold some secrets to how we age and get cancer.

Telomeres have been compared with the plastic tips on shoelaces

because they prevent chromosome ends from fraying and sticking to each other,

which would scramble an organism's genetic information to cause cancer,

other diseases or death.

Each time a cell divides, the telomeres get shorter. When they get too short,

the cell no longer can divide and becomes inactive or "senescent" or dies.

This process is associated with aging, cancer and a higher risk of death.

ttp://biochemistry.ucsf.edu/labs/blackburn/index.php?option=com_content&view=article&id=1&Itemid=3

The research on the power of Polyphenols to protect telomeres

has seen dramatic growth in the past 2 years. With every passing day,

We are discovering the true health and healing properties of Vivix — truly

a one-of-a-kind product. 

**Reminder: FREE MEMBERSHIP....Don't MISS out!

**Please don't forget to come and visit me online and sign up for your "FREE" Membership with only a $30 purchase!!!   


You will save 15% off every time you order and the greatest part is Shaklee offers a 100% Money Back Guarantee anytime!   You have nothing to loose....I promise!


This offer ends this coming Friday, May 20th, 2011....PLEASE hurry and be a part of this "AMAZING" deal.

Shaklee Videos: Gwyneth Paltrow and Shaklee Share Common Values

Shaklee Videos: Gwyneth Paltrow and Shaklee Share Common Values

In "Honor" of Earth Day!

Our Families "Personal" Tragedy......

PLEASE COME & READ THIS & SHARE IT WITH OTHERS 

(Story of my fathers death due to "Bad" Medicine (literally!)

Bob's Story

"FREE" Cinch Sampler Pack with $70 order....DON'T MISS OUT!

~Please come & visit my website anytime and if you place a $70 Shaklee order you'll get our "Cinch" Sampler Pack FREE!!!!!    The value of the pack is around $100 which includes our Vanilla Cinch shakes, our Pomegranate Energizing Tea (one of my favorite products) and our Peanut Butter Snack bars~




**Offer ends March 31st, 2011

FDA concerned about Fosamax, Actonel, Boniva, Atelvia & Reclast......

Lawyers are working on class action lawsuits against the pharmaceutical companies selling Fosamax, Actonel, Boniva, Atelvia, and Reclast--and other versions, including generics, of these "bisphosphates."  

(I found this FDA news release from Oct. 13, 2010.)

A lot of us have been alerting women for YEARS not to take these.  My understanding is that they do an unnatural thing.  To increase bone density, they stop dead bone cells from sloughing off the way nature designed them to do--the natural process.  So the dead cells stay in there to increase bone density--certainly not the natural, healthy way to increase bone density.  (Diane Petoskey, nutritionist, called this “mushy bones”. ) 

My business colleague was prescribed one of these products and instead of taking it, continued to take all the good SHAKLEE basics, and increased OsteoMatrix and exercise (to let the bone know the body is active and needs stronger bones).  Her bone density increased in a short time, impressing the doctor. 

FDA NEWS RELEASE

For Immediate Release: Oct. 13, 2010
Media Inquiries: Karen Riley, 301-796-4674, karen.riley@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA
 
FDA: Possible increased risk of thigh bone fracture with bisphosphonates

Labeling change adds warning about possible risks of long-term use of osteoporosis drugs 

The U.S. Food and Drug Administration today warned patients and health care providers about the possible risk of atypical thigh bone (femoral) fracture in patients who take bisphosphonates, a class of drugs used to prevent and treat osteoporosis. A labeling change and Medication Guide will reflect this risk.

Bisphosphonates inhibit the loss of bone mass in people with osteoporosis. Bisphosphonates have been shown to reduce the rate of osteoporotic fractures -- fractures that can result in pain, hospitalization, and surgery-- in people with osteoporosis. While it is not clear whether bisphosphonates are the cause, atypical femur fractures, a rare but serious type of thigh bone fracture, have been predominantly reported in patients taking bisphosphonates. The optimal duration of bisphosphonate use for osteoporosis is unknown, and the FDA is highlighting this uncertainty because these fractures may be related to use of bisphosphonates for longer than five years.

The labeling changes and Medication Guide will affect only those bisphosphonates approved for osteoporosis, including oral bisphosphonates such as Fosamax, Fosamax Plus D, Actonel, Actonel with Calcium, Boniva, Atelvia, and their generic products, as well as injectable bisphosphonates such as Reclast and Boniva.

Labeling changes and the Medication Guide will not apply to bisphosphonates used for Paget’s disease or cancer/hypercalcemia such as Didronel, Zometa, Skelid, and their generic products.

“The FDA is continuing to evaluate data about the safety and effectiveness of bisphosphonates when used long-term for osteoporosis treatment,” said RADM Sandra Kweder, M.D., deputy director, Office of New Drugs in the FDA’s Center for Drug Evaluation and Research. "In the interim, it’s important for patients and health care professionals to have all the safety information available when determining the best course of treatment for osteoporosis.”

Today’s warning follows a March 10, 2010, Drug Safety Communication announcing the FDA’s ongoing safety review of bisphosphonate use and the occurrence of atypical femur fractures. The FDA has since reviewed all available data on bisphosphonate use, including data summarized in the American Society for Bone Mineral Research Task Force report. The report recommended additional product labeling, better identification and tracking of patients experiencing these breaks, and more research to determine whether and how these drugs cause the serious but uncommon fractures.

Based on the FDA’s review, the Warnings and Precautions section of all bisphosphonate products for osteoporosis will be revised, and the FDA will require the inclusion of a Medication Guide to better inform patients of the possible increased fracture risk.

The FDA recommends that health care professionals be aware of the possible risk in patients taking bisphosphonates and consider periodic reevaluation of the need for continued bisphosphonate therapy for patients who have been on bisphosphonates for longer than five years.

Patients taking bisphosphonates for osteoporosis should not stop using their medication unless told to do so by their health care professional. Those taking bisphosphonates also should report any new thigh or groin pain to their health care provider and be evaluated for a possible femur fracture. Patients and health care professionals should report side effects with the use of bisphosphonates to the FDA’s MedWatch Adverse Event Reporting program at www.fda.gov/MedWatch or by calling (800) 332-1088.

For more information:

FDA Drug Safety CommunicationConsumer Update: Possible Fracture Risk With Osteoporosis DrugsLetters to Sponsor/Applicants Requesting Labeling Changes

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm229171.htm

I intend this as an information service.  If you want to be removed from this list, simply click on the REPLY button, type REMOVE in the subject line, and click on SEND.  Shirley Koritnik, AIR APPARENT, 1639 Fairview Blvd, Winston-Salem, North Carolina 27127. Thanks!

Fosamax lawsuit/side effects

Fosamax is Merck's $3 billion per year osteoporosis drug that's drawing fresh controversy with a court battle over an unusual side effect.

According to the Associated Press (AP), a lawsuit filed in Florida claims that Merck has been negligent by attempting to downplay one of the drug's side effects.

A New England Journal of Medicine report linked Fosamax (and other drugs in a class of pharmaceuticals known as bisphosphonates) with ocular inflammation.  When untreated, this condition causes blurred vision, swelling and even blindness.

The Florida lawsuit highlights another unusual bisphosphonate side effect: osteonecrosis of the jaw; also known as "jaw necrosis" or "jaw death," prompted by a loss of blood supply to the jawbone.  The suit has been filed on behalf of 250 Fosamax users who developed this condition.

The AP article notes that Merck representatives responded to the suit by stating that no cases of osteonecrosis of the jaw were reported among more than 17,000 subjects in clinical trials.  Nevertheless, in January 2005 the FDA directed Merck to update the Fosamax label with a warning about the side effect.  The company complied later in the year, but the lawsuit claims that the warning is not sufficient.

According to the Fosamax web site, other side effects include inflammation and ulceration of the esophagus, painful swallowing, stomach pain, indigestion and nausea.

Source:  Health Sciences Institute, May 3, 2006